chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aplastic anaemia, Biopsy bone marrow, Blood count, Blood test, Haemoglobin decreased
Clinical narrative: I received it on Monday, I went in to donate blood on Friday, the 8th. They told me my hemoglobin level was below their minimum standards. I had to go home to take vitamins for a couple of weeks. It hadn't happened to me before. I went back on the 26th of January. At that point, my hemoglobin was in the 7's from 12. They recommended to see my doctor. I went on the 29th. When I went to see my doctor, they said I needed to go to the hospital immediately. I was in 5 for hemoglobin. They did all kinds of tests and checks. They didn't know what was causing it. They diagnosed - Aplastic Anemia. That first weekend, I met Dr. , Internal Medicine. I had 0 ANC baby white blood cells. They got me on to a program by Wednesday at hospital. they flew me out there and got me on this program. I have been on it ever sense.  Cyclosporine and Eltrombopog - They got me on those.  A week later when I was still out there - a horse ATG - a bag drip - a transfusion drug - for four days - a drip for 6-8 hours a day.  They put me on Nutrapina Diet.   That is suppose to resurrect of change the t-cells in my blood from attacking my system to helping it. The Cyclosporine is suppose to suppress my immune system so it isn't attacking me. The other  - Eltrombopog is to encourage growth for my ANCs - baby white blood cells. I stayed in the hospital to 2-25-2021. They sent me home with seven or eight different drugs: anti-inflammatory and anti-biotic and anti- everything. I was on for the next month, weaning off now and then. They would watch my blood counts - I went in for twice a week, minimum, and they were also being sent to the hospital. Three months later, in May, I went back, and they did a re-check of all my bone marrow and blood count and everything else. I will be going back on the 9th of August - I'll be knowledgeable in bone marrow transport in case this doesn't work. The drawback to drug therapy - after a year, it starts to screw up my existing bone marrow. If I do bone marrow transport - I'm at an age where it's only 70% cure. I have talked to the lots of different hospitals. A week from Monday, I'll be going to get final wrap-up from all the experts.  Initially, I responded very well - 18 days out- faster than normal to respond. I have been going slow since then...I should be off the stuff by now - is what they are thinking.  I'm on low levels for baby white cells,  platelets, I go back to the doctor -  every week to get  blood draws and to get  units of blood - .5 - ANC - yesterday - so still below. My platelets, yesterday, 21 or 22, highest is has ever been. I have to be at 113 - 164 for those. Hemoglobin level: yesterday: 7.8. The previous year, I am on the fire department - we would get tested for COVID. Back then, we were being tested for any antibodies that said if we had had COVID - and if my body was  producing anything - I always tested negative. They made an offer for me to get the vaccine. I can't go more than a week without transfusions.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neutrophil count decreased, Platelet count decreased, Transfusion
Clinical narrative: I received it on Monday, I went in to donate blood on Friday, the 8th. They told me my hemoglobin level was below their minimum standards. I had to go home to take vitamins for a couple of weeks. It hadn't happened to me before. I went back on the 26th of January. At that point, my hemoglobin was in the 7's from 12. They recommended to see my doctor. I went on the 29th. When I went to see my doctor, they said I needed to go to the hospital immediately. I was in 5 for hemoglobin. They did all kinds of tests and checks. They didn't know what was causing it. They diagnosed - Aplastic Anemia. That first weekend, I met Dr. , Internal Medicine. I had 0 ANC baby white blood cells. They got me on to a program by Wednesday at hospital. they flew me out there and got me on this program. I have been on it ever sense.  Cyclosporine and Eltrombopog - They got me on those.  A week later when I was still out there - a horse ATG - a bag drip - a transfusion drug - for four days - a drip for 6-8 hours a day.  They put me on Nutrapina Diet.   That is suppose to resurrect of change the t-cells in my blood from attacking my system to helping it. The Cyclosporine is suppose to suppress my immune system so it isn't attacking me. The other  - Eltrombopog is to encourage growth for my ANCs - baby white blood cells. I stayed in the hospital to 2-25-2021. They sent me home with seven or eight different drugs: anti-inflammatory and anti-biotic and anti- everything. I was on for the next month, weaning off now and then. They would watch my blood counts - I went in for twice a week, minimum, and they were also being sent to the hospital. Three months later, in May, I went back, and they did a re-check of all my bone marrow and blood count and everything else. I will be going back on the 9th of August - I'll be knowledgeable in bone marrow transport in case this doesn't work. The drawback to drug therapy - after a year, it starts to screw up my existing bone marrow. If I do bone marrow transport - I'm at an age where it's only 70% cure. I have talked to the lots of different hospitals. A week from Monday, I'll be going to get final wrap-up from all the experts.  Initially, I responded very well - 18 days out- faster than normal to respond. I have been going slow since then...I should be off the stuff by now - is what they are thinking.  I'm on low levels for baby white cells,  platelets, I go back to the doctor -  every week to get  blood draws and to get  units of blood - .5 - ANC - yesterday - so still below. My platelets, yesterday, 21 or 22, highest is has ever been. I have to be at 113 - 164 for those. Hemoglobin level: yesterday: 7.8. The previous year, I am on the fire department - we would get tested for COVID. Back then, we were being tested for any antibodies that said if we had had COVID - and if my body was  producing anything - I always tested negative. They made an offer for me to get the vaccine. I can't go more than a week without transfusions.
Age: 46.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Facial discomfort, Limb discomfort, Paraesthesia, Sensory loss, Somnolence
Clinical narrative: Slight demyelination of the trigeminal nerve.
Age: 46.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Tongue discomfort
Clinical narrative: Slight demyelination of the trigeminal nerve.
Age: 46.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Demyelination, Trigeminal nerve disorder
Clinical narrative: Slight demyelination of the trigeminal nerve.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Impaired driving ability
Clinical narrative: Experienced fast heart beat within 40 mins after receiving first shot.; This is a spontaneous report from Non-contactable other HCP. A 44-year-old non-pregnant female patient first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ep7534), via an unspecified route of administration on arm left on 15Mar2021 10:30 AM (Age at Vaccination: 44 years) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history included pre-diabetic and had no known allergies. If other vaccine in four weeks and other medications in two weeks was reported as no. If covid prior vaccination and If covid tested post vaccination was reported as no. The patient Concomitant medications were not reported. On 15Mar2021 11:00 AM, the patient experienced fast heart beat within 40 mins after receiving first shot. The treatment received as a result of events was reported as no. The outcome of the event was recovered on an unknown date in Mar2021
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased
Clinical narrative: Experienced fast heart beat within 40 mins after receiving first shot.; This is a spontaneous report from Non-contactable other HCP. A 44-year-old non-pregnant female patient first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ep7534), via an unspecified route of administration on arm left on 15Mar2021 10:30 AM (Age at Vaccination: 44 years) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history included pre-diabetic and had no known allergies. If other vaccine in four weeks and other medications in two weeks was reported as no. If covid prior vaccination and If covid tested post vaccination was reported as no. The patient Concomitant medications were not reported. On 15Mar2021 11:00 AM, the patient experienced fast heart beat within 40 mins after receiving first shot. The treatment received as a result of events was reported as no. The outcome of the event was recovered on an unknown date in Mar2021
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Palpitations, Skin warm, Tongue eruption
Clinical narrative: experienced heart palpitation and red rash after her 1st dose; experienced heart palpitation and red rash after her 1st dose; This is a spontaneous report from a Pfizer Sponsored Program.   A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown, Expiration date: unknown), via unspecified route of administration, on 05Mar2021, as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On 05Mar2021, the patient experienced heart palpitation and red rash. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Rash erythematous
Clinical narrative: experienced heart palpitation and red rash after her 1st dose; experienced heart palpitation and red rash after her 1st dose; This is a spontaneous report from a Pfizer Sponsored Program.   A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown, Expiration date: unknown), via unspecified route of administration, on 05Mar2021, as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On 05Mar2021, the patient experienced heart palpitation and red rash. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 93.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Asthenia, Body temperature, Fatigue, Heart rate, Malaise
Clinical narrative: She said after her father got his first COVID-19 Vaccine shot, in a couple days, he felt drained and had no energy; her father had 2-3 spells with his stomach in that he threw up; Tiredness; her father to not feel well; This is a spontaneous report from a contactable consumer (patient's daughter). A 94-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date: unknown), via an unspecified route of administration, administered in right arm on 29Jan2021 (at the age of 93-years-old) as dose 1, single for covid-19 immunisation, Lidocaine hcl (LIDOCAINE HCL), via an unspecified route of administration from 2021 (Batch/Lot number was not reported) to an unspecified date, at Patch with 4% Lidocaine for right shoulder and right arm trouble. Medical history included skin cancer on his one ear from an unknown date and unknown if ongoing. Patient's daughter reported that, her father got his first covid-19 vaccine shot, in a couple days, he felt drained and had no energy, he had 2-3 spells with his stomach, in that he threw up, tiredness and weakness on an unspecified date in 2021. She said she had checked her father's vital signs, and his heart rate, oxygen level, and temperature were ok. She said her father had no fever. The reporter stated that she was not sure if either the patches, or the COVID-19 Vaccine may be causing her father to not feel well. Reported on 18Feb2021 that her father said he felt a little better, but on 19Feb2021 her father said he felt tired and weak again. She also reported that, before her father received his first covid-19 vaccine dose, he had trouble with his right shoulder and right arm. She said her father's doctor gave her father some patches for his right shoulder and right arm around the same time her father got his first covid-19 vaccine shot. She said her father was supposed to get his second covid-19 vaccine dose on 19Feb2021 but was told by the pharmacist he had up to 6 weeks to receive the second covid-19 vaccine dose. She said her father had always gotten around good, and her father doesn't drink or smoke. Reported her father usually has blood work every couple of months, and her father's doctor follows her father closely. The event did not require emergency room or physician office visit. Patient did not receive any prior vaccinations within 4 weeks. The outcome of events he had 2-3 spells with his stomach her father to not feel well were unknown and other events were not resolved.   No follow-up attempts are needed; information about lot/batch number cannot been obtained. No further information is expected.
Age: 93.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Oxygen saturation, Vomiting
Clinical narrative: She said after her father got his first COVID-19 Vaccine shot, in a couple days, he felt drained and had no energy; her father had 2-3 spells with his stomach in that he threw up; Tiredness; her father to not feel well; This is a spontaneous report from a contactable consumer (patient's daughter). A 94-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date: unknown), via an unspecified route of administration, administered in right arm on 29Jan2021 (at the age of 93-years-old) as dose 1, single for covid-19 immunisation, Lidocaine hcl (LIDOCAINE HCL), via an unspecified route of administration from 2021 (Batch/Lot number was not reported) to an unspecified date, at Patch with 4% Lidocaine for right shoulder and right arm trouble. Medical history included skin cancer on his one ear from an unknown date and unknown if ongoing. Patient's daughter reported that, her father got his first covid-19 vaccine shot, in a couple days, he felt drained and had no energy, he had 2-3 spells with his stomach, in that he threw up, tiredness and weakness on an unspecified date in 2021. She said she had checked her father's vital signs, and his heart rate, oxygen level, and temperature were ok. She said her father had no fever. The reporter stated that she was not sure if either the patches, or the COVID-19 Vaccine may be causing her father to not feel well. Reported on 18Feb2021 that her father said he felt a little better, but on 19Feb2021 her father said he felt tired and weak again. She also reported that, before her father received his first covid-19 vaccine dose, he had trouble with his right shoulder and right arm. She said her father's doctor gave her father some patches for his right shoulder and right arm around the same time her father got his first covid-19 vaccine shot. She said her father was supposed to get his second covid-19 vaccine dose on 19Feb2021 but was told by the pharmacist he had up to 6 weeks to receive the second covid-19 vaccine dose. She said her father had always gotten around good, and her father doesn't drink or smoke. Reported her father usually has blood work every couple of months, and her father's doctor follows her father closely. The event did not require emergency room or physician office visit. Patient did not receive any prior vaccinations within 4 weeks. The outcome of events he had 2-3 spells with his stomach her father to not feel well were unknown and other events were not resolved.   No follow-up attempts are needed; information about lot/batch number cannot been obtained. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Lymphadenopathy, Tenderness
Clinical narrative: discomfort under left arm.; Looked in mirror, and the lymph node under my left arm was swollen the size of a tennis ball (approx 5" diameter) and hanging down under my arm pit 4".; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL3247) via an unspecified route of administration in the left arm on 08Mar2021 at 08:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL3302) via an unspecified route of administration in the left arm on 15Feb2021 at 16:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Mar2021 at 05:00, the patient woke up and had discomfort under his left arm. He looked in mirror, and the lymph node under his left arm was swollen the size of a tennis ball (approximately 5" diameter) and it was hanging down under his arm pit 4".  The patient pushed the lymph node up under his armpit, squeezed and held his arm against his left side for 1 hour.  He then used an ice pack and heating pad throughout the day to help reduce the swelling and discomfort.  After about 2 hours the lymph node stayed up under his arm pit.  The patient further reported that his lymph node was still swollen approximately 2" with slight discomfort.  It has been a month since his second dose and this is the only side effect that he had from receiving the COVID 19 vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of swollen lymph node and treatment included himself with ice pack and heating pad. The clinical outcome of the events discomfort under left arm and swollen lymph nodes was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Lymphadenopathy
Clinical narrative: discomfort under left arm.; Looked in mirror, and the lymph node under my left arm was swollen the size of a tennis ball (approx 5" diameter) and hanging down under my arm pit 4".; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL3247) via an unspecified route of administration in the left arm on 08Mar2021 at 08:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL3302) via an unspecified route of administration in the left arm on 15Feb2021 at 16:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Mar2021 at 05:00, the patient woke up and had discomfort under his left arm. He looked in mirror, and the lymph node under his left arm was swollen the size of a tennis ball (approximately 5" diameter) and it was hanging down under his arm pit 4".  The patient pushed the lymph node up under his armpit, squeezed and held his arm against his left side for 1 hour.  He then used an ice pack and heating pad throughout the day to help reduce the swelling and discomfort.  After about 2 hours the lymph node stayed up under his arm pit.  The patient further reported that his lymph node was still swollen approximately 2" with slight discomfort.  It has been a month since his second dose and this is the only side effect that he had from receiving the COVID 19 vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of swollen lymph node and treatment included himself with ice pack and heating pad. The clinical outcome of the events discomfort under left arm and swollen lymph nodes was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Tongue discolouration
Clinical narrative: Strong tightness sensation around tongue (presumed mild swelling); Red splotch (nickel to quarter size) appearing on top of tongue; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 18Mar2021 at 15:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease, autoimmune small fiber polyneuropathy, dysautonomia and unspecified allergies to medications, food or other products. The patient received unspecified medication within two weeks of the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 16:00 the patient experienced strong tightness sensation around tongue (presumed mild swelling) with red splotch (nickel to quarter size) that appeared on top of tongue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse event and included treatment with BENADRYL 50mg. The clinical outcome of the event strong tightness sensation around tongue (presumed mild swelling) with red splotch (nickel to quarter size) that appeared on top of tongue were resolved on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue, Tongue eruption
Clinical narrative: Strong tightness sensation around tongue (presumed mild swelling); Red splotch (nickel to quarter size) appearing on top of tongue; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 18Mar2021 at 15:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease, autoimmune small fiber polyneuropathy, dysautonomia and unspecified allergies to medications, food or other products. The patient received unspecified medication within two weeks of the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 16:00 the patient experienced strong tightness sensation around tongue (presumed mild swelling) with red splotch (nickel to quarter size) that appeared on top of tongue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse event and included treatment with BENADRYL 50mg. The clinical outcome of the event strong tightness sensation around tongue (presumed mild swelling) with red splotch (nickel to quarter size) that appeared on top of tongue were resolved on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Fever up to 102 for three days; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN), sulfas, amoxicillin (MANUFACTURER UNKNOWN) and sulfamethoxazole, trimethoprim (BACTRIM). Concomitant medication included ethinylestradiol, norgestimate (ORTHOCYCLEN), from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 05Apr2021 at 19:00, the patient experienced sore arm and fever up to 102 for three days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of sore arm and fever up to 102 which included treatment with Ibuprofen (MANUFACTURER UNKNOWN). The clinical outcome sore arm and fever up to 102 was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Fever up to 102 for three days; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN), sulfas, amoxicillin (MANUFACTURER UNKNOWN) and sulfamethoxazole, trimethoprim (BACTRIM). Concomitant medication included ethinylestradiol, norgestimate (ORTHOCYCLEN), from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 05Apr2021 at 19:00, the patient experienced sore arm and fever up to 102 for three days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of sore arm and fever up to 102 which included treatment with Ibuprofen (MANUFACTURER UNKNOWN). The clinical outcome sore arm and fever up to 102 was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Chills, Decreased appetite, Dizziness
Clinical narrative: Total fatigue; lack of energy; sleeplessness; headache; recurring chills; muscle & joint pains allover; muscle & joint pains allover; nausea; appetite & weight loss for 6 days; weight loss; blurred vision; dizziness; Pretty motionless; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), via an unspecified route of administration in the left arm on an unspecified date at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included aortic valve replacement on 12Jan1999 and FINE; allergy to insect stings, spine and joint deterioration and osteoarthritis. The patient also reported that she was under specialists' care for these and being monitored. Concomitant medications included warfarin (WARFARINE), atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), fenofibrate (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198), via an unspecified route of administration in the left arm on an unspecified date at 11:00, as a single dose for COVID-19 immunisation. The patient previously received codeine (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), celebrex (MANUFACTURER UNKNOWN), salsalate (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN), cefuroxime (MANUFACTURER UNKNOWN), nitrofurantoin (MANUFACTURER UNKNOWN), clindamycin (MANUFACTURER UNKNOWN), ciprofloxacin (MANUFACTURER UNKNOWN) and methocarbamol (MANUFACTURER UNKNOWN); all for unknown indications on unknown dates and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021 at 13:00, the patient experienced total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and was pretty motionless until 8th day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcomes of the events total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and pretty motionless until 8th day were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Insomnia, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: Total fatigue; lack of energy; sleeplessness; headache; recurring chills; muscle & joint pains allover; muscle & joint pains allover; nausea; appetite & weight loss for 6 days; weight loss; blurred vision; dizziness; Pretty motionless; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), via an unspecified route of administration in the left arm on an unspecified date at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included aortic valve replacement on 12Jan1999 and FINE; allergy to insect stings, spine and joint deterioration and osteoarthritis. The patient also reported that she was under specialists' care for these and being monitored. Concomitant medications included warfarin (WARFARINE), atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), fenofibrate (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198), via an unspecified route of administration in the left arm on an unspecified date at 11:00, as a single dose for COVID-19 immunisation. The patient previously received codeine (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), celebrex (MANUFACTURER UNKNOWN), salsalate (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN), cefuroxime (MANUFACTURER UNKNOWN), nitrofurantoin (MANUFACTURER UNKNOWN), clindamycin (MANUFACTURER UNKNOWN), ciprofloxacin (MANUFACTURER UNKNOWN) and methocarbamol (MANUFACTURER UNKNOWN); all for unknown indications on unknown dates and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021 at 13:00, the patient experienced total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and was pretty motionless until 8th day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcomes of the events total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and pretty motionless until 8th day were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Vision blurred
Clinical narrative: Total fatigue; lack of energy; sleeplessness; headache; recurring chills; muscle & joint pains allover; muscle & joint pains allover; nausea; appetite & weight loss for 6 days; weight loss; blurred vision; dizziness; Pretty motionless; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), via an unspecified route of administration in the left arm on an unspecified date at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included aortic valve replacement on 12Jan1999 and FINE; allergy to insect stings, spine and joint deterioration and osteoarthritis. The patient also reported that she was under specialists' care for these and being monitored. Concomitant medications included warfarin (WARFARINE), atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), fenofibrate (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198), via an unspecified route of administration in the left arm on an unspecified date at 11:00, as a single dose for COVID-19 immunisation. The patient previously received codeine (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), celebrex (MANUFACTURER UNKNOWN), salsalate (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN), cefuroxime (MANUFACTURER UNKNOWN), nitrofurantoin (MANUFACTURER UNKNOWN), clindamycin (MANUFACTURER UNKNOWN), ciprofloxacin (MANUFACTURER UNKNOWN) and methocarbamol (MANUFACTURER UNKNOWN); all for unknown indications on unknown dates and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021 at 13:00, the patient experienced total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and was pretty motionless until 8th day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcomes of the events total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and pretty motionless until 8th day were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Insomnia, Loss of personal independence in daily activities, Myalgia
Clinical narrative: Total fatigue; lack of energy; sleeplessness; headache; recurring chills; muscle & joint pains allover; muscle & joint pains allover; nausea; appetite & weight loss for 6 days; weight loss; blurred vision; dizziness; Pretty motionless; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), via an unspecified route of administration in the left arm on an unspecified date at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included aortic valve replacement on 12Jan1999 and FINE; allergy to insect stings, spine and joint deterioration and osteoarthritis. The patient also reported that she was under specialists' care for these and being monitored. Concomitant medications included warfarin (WARFARINE), atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), fenofibrate (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198), via an unspecified route of administration in the left arm on an unspecified date at 11:00, as a single dose for COVID-19 immunisation. The patient previously received codeine (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), celebrex (MANUFACTURER UNKNOWN), salsalate (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN), cefuroxime (MANUFACTURER UNKNOWN), nitrofurantoin (MANUFACTURER UNKNOWN), clindamycin (MANUFACTURER UNKNOWN), ciprofloxacin (MANUFACTURER UNKNOWN) and methocarbamol (MANUFACTURER UNKNOWN); all for unknown indications on unknown dates and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021 at 13:00, the patient experienced total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and was pretty motionless until 8th day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcomes of the events total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and pretty motionless until 8th day were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Vision blurred, Weight decreased
Clinical narrative: Total fatigue; lack of energy; sleeplessness; headache; recurring chills; muscle & joint pains allover; muscle & joint pains allover; nausea; appetite & weight loss for 6 days; weight loss; blurred vision; dizziness; Pretty motionless; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), via an unspecified route of administration in the left arm on an unspecified date at 11:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included aortic valve replacement on 12Jan1999 and FINE; allergy to insect stings, spine and joint deterioration and osteoarthritis. The patient also reported that she was under specialists' care for these and being monitored. Concomitant medications included warfarin (WARFARINE), atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN), fenofibrate (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198), via an unspecified route of administration in the left arm on an unspecified date at 11:00, as a single dose for COVID-19 immunisation. The patient previously received codeine (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN), celebrex (MANUFACTURER UNKNOWN), salsalate (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN), cefuroxime (MANUFACTURER UNKNOWN), nitrofurantoin (MANUFACTURER UNKNOWN), clindamycin (MANUFACTURER UNKNOWN), ciprofloxacin (MANUFACTURER UNKNOWN) and methocarbamol (MANUFACTURER UNKNOWN); all for unknown indications on unknown dates and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021 at 13:00, the patient experienced total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and was pretty motionless until 8th day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcomes of the events total fatigue and lack of energy, sleeplessness, headache, recurring chills; muscle and joint pains all over, nausea, appetite and weight loss for 6 days, blurred vision; dizziness and pretty motionless until 8th day were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dysgeusia, Feeling hot, Flushing, Tachycardia
Clinical narrative: Immediate metallic taste, lightheadedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious ), tachycardia, flushed skin, this lasted 5 minutes.  It did subside.; Immediate metallic taste, lightheadedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious ), tachycardia, flushed skin, this lasted 5 minutes.  It did subside.; Immediate metallic taste, lightheadedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious ), tachycardia, flushed skin, this lasted 5 minutes.  It did subside.; almost passing out (did not pass out, was always conscious); tachycardia, flushed skin this lasted 5 minutes. It did subside. Later that  day had localized hives that went away; tachycardia, flushed skin this lasted 5 minutes. It did subside. Later that  day had localized hives that went away; localized hives that went away; This is a spontaneous report from a contactable consumer. A 32-year-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0153) via an unspecified route of administration administered in left arm on 06Apr2021 12:00 Pm (at the age of 32-years-old) as a single dose for covid-19 immunisation. Medical history included autoimmune disorder. Concomitant medication(s) included mycophenolate mofetil (CELLCEPT [MYCOPHENOLATE MOFETIL]) taken for an unspecified indication, start and stop date were not reported. patient had known allergies Penicillin, shellfish, contrast dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 12:00 Pm, the patient experienced Immediate metallic taste, light-headedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious), tachycardia, flushed skin, this lasted 5 minutes. It did subside. Later that day had localized hives that went away. No treatment received for adverse events. The outcome of the event flushed skin was recovered on 06Apr2021 12:05 and other events were recovered on unspecified date on 2021.  No follow up attempts are possible. Information about lot/batch number cannot be requested.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Immediate metallic taste, lightheadedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious ), tachycardia, flushed skin, this lasted 5 minutes.  It did subside.; Immediate metallic taste, lightheadedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious ), tachycardia, flushed skin, this lasted 5 minutes.  It did subside.; Immediate metallic taste, lightheadedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious ), tachycardia, flushed skin, this lasted 5 minutes.  It did subside.; almost passing out (did not pass out, was always conscious); tachycardia, flushed skin this lasted 5 minutes. It did subside. Later that  day had localized hives that went away; tachycardia, flushed skin this lasted 5 minutes. It did subside. Later that  day had localized hives that went away; localized hives that went away; This is a spontaneous report from a contactable consumer. A 32-year-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0153) via an unspecified route of administration administered in left arm on 06Apr2021 12:00 Pm (at the age of 32-years-old) as a single dose for covid-19 immunisation. Medical history included autoimmune disorder. Concomitant medication(s) included mycophenolate mofetil (CELLCEPT [MYCOPHENOLATE MOFETIL]) taken for an unspecified indication, start and stop date were not reported. patient had known allergies Penicillin, shellfish, contrast dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 12:00 Pm, the patient experienced Immediate metallic taste, light-headedness, warm sensation head to toe, almost passing out (did not pass out, was always conscious), tachycardia, flushed skin, this lasted 5 minutes. It did subside. Later that day had localized hives that went away. No treatment received for adverse events. The outcome of the event flushed skin was recovered on 06Apr2021 12:05 and other events were recovered on unspecified date on 2021.  No follow up attempts are possible. Information about lot/batch number cannot be requested.